SCOPUS 정보 검색 플랫폼

Angewandte Chemie - International Edition

Volumn 47, Issue 26, 2008, Pages 4922-4925

Silicon-based building blocks for one-step18F-radiolabeling of peptides for PET imaging

(11) Mu, Linjing a Höhne, Aileen a Schubiger, P August a Ametamey, Simon M a Graham, Keith b Cyr, John E b Dinkelborg, Ludger b Stellfeld, Timo b Srinivasan, Ananth b Voigtmann, Ulrike b Klar, Ulrich b

a ETH ZURICH (Switzerland)

b BAYER PHARMA AG (Germany)

Author keywords

Fluorine; Peptides; PET imaging; Radiolabeling; Silicon

Indexed keywords

FLUORINE; PEPTIDES; PET IMAGING; RADIOLABELING;

SILICON;

FLUORINE; PEPTIDE; SILICON;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; TIME;

FLUORINE RADIOISOTOPES; MOLECULAR STRUCTURE; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; SILICON; TIME FACTORS;

EID: 48849105873 PISSN: 14337851 EISSN: None Source Type: Journal
DOI: 10.1002/anie.200705854 Document Type: Article

Times cited : (102)

References (34)

1
- 28544446939
- a) F. Roesch, G. Gruender, M. Schreckenberger, G. Dannhardt, Pharm. Unserer Zeit 2005, 34, 474-482;
- (2005) Pharm. Unserer Zeit , vol.34 , pp. 474-482
- Roesch, F.¹ Gruender, G.² Schreckenberger, M.³ Dannhardt, G.⁴

2
- 53549123998
- b) A. R. Troiano, A. J. Stoessl, Bioimaging Neurodegener. 2005, 25-35;
- (2005) Bioimaging Neurodegener , pp. 25-35
- Troiano, A.R.¹ Stoessl, A.J.²

3
- 24644471138
- c) R. Sanchez-Pernaute, A.-L. Brownell, B. G. Jenkins, O. Isacson, Toxicol. Appl. Pharmacol. 2005, 207, S251-S256;
- (2005) Toxicol. Appl. Pharmacol , vol.207
- Sanchez-Pernaute, R.¹ Brownell, A.-L.² Jenkins, B.G.³ Isacson, O.⁴

4
- 33846032313
- d) L. Cai, R. B. Innis, V. W. Pike, Curr. Med. Chem. 2007, 14, 19-52;
- (2007) Curr. Med. Chem , vol.14 , pp. 19-52
- Cai, L.¹ Innis, R.B.² Pike, V.W.³

5
- 34249007642
- e) R. M. Cohen, Mol. Imaging Biol. 2007, 9, 204-216;
- (2007) Mol. Imaging Biol , vol.9 , pp. 204-216
- Cohen, R.M.¹

6
- 34848881371
- f) J. R. Mercer, J. Pharm. Pharm. Sci. 2007, 10, 180-202;
- (2007) J. Pharm. Pharm. Sci , vol.10 , pp. 180-202
- Mercer, J.R.¹

7
- 33750357722
- g) N. Oriuchi, T. Higuchi, T. Ishikita, M. Miyakubo, H. Hanaoka, Y. Iida, K. Endo, Cancer Sci. 2006, 97, 1291-1297;
- (2006) Cancer Sci , vol.97 , pp. 1291-1297
- Oriuchi, N.¹ Higuchi, T.² Ishikita, T.³ Miyakubo, M.⁴ Hanaoka, H.⁵ Iida, Y.⁶ Endo, K.⁷

8
- 33750876492
- h) D. Le Bars, J. Fluorine Chem. 2006, 127, 1488-1493;
- (2006) J. Fluorine Chem , vol.127 , pp. 1488-1493
- Le Bars, D.¹

9
- 53549125702
- PET and Molecular Imaging, 158-165;
- i) H. Fukuda, S. Furumoto, R. Iwata, K. Kubota, Int. Congr. Ser. 2004, 1264 (PET and Molecular Imaging), 158-165;
- (2004) Int. Congr. Ser , vol.1264
- Fukuda, H.¹ Furumoto, S.² Iwata, R.³ Kubota, K.⁴

10
- 53549101165
- j) A. M. Scott, Positron Emiss. Tomogr. 2005, 311-325;
- (2005) Positron Emiss. Tomogr , pp. 311-325
- Scott, A.M.¹

11
- 0034154862
- k) M. N. Maisey, Nucl. Med. Commun. 2000, 21, 234-236;
- (2000) Nucl. Med. Commun , vol.21 , pp. 234-236
- Maisey, M.N.¹

12
- 53549123719
- l) S. Furst, MTA 1999, 14, 506-508, 510.
- (1999) MTA , vol.14 , Issue.506-508 , pp. 510
- Furst, S.¹

13
- 0027133128
- a) A. J. Fischman, J. W. Babich, H. W. Strauss, J. Nucl. Med. 1993, 34, 2253-2263;
- (1993) J. Nucl. Med , vol.34 , pp. 2253-2263
- Fischman, A.J.¹ Babich, J.W.² Strauss, H.W.³

14
- 0032750819
- b) D. Blok, R. I. J. Feitsma, P. Vermeij, E. K. J. Pauwels, Eur. J. Nucl. Med. 1999, 26, 1511-1519;
- (1999) Eur. J. Nucl. Med , vol.26 , pp. 1511-1519
- Blok, D.¹ Feitsma, R.I.J.² Vermeij, P.³ Pauwels, E.K.J.⁴

15
- 0030221012
- c) J. C. McAfee, R. D. Neumann, Nucl. Med. Biol. 1996, 23, 673-676;
- (1996) Nucl. Med. Biol , vol.23 , pp. 673-676
- McAfee, J.C.¹ Neumann, R.D.²

16
- 0034911579
- d) S. M. Okarvi, Eur. J. Nucl. Med. 2001, 28, 929-938;
- (2001) Eur. J. Nucl. Med , vol.28 , pp. 929-938
- Okarvi, S.M.¹

17
- 0029945878
- e) H. J. Wester, K. Hamacher, G. Stöcklin, Nucl. Med. Biol. 1996, 23, 365-372.
- (1996) Nucl. Med. Biol , vol.23 , pp. 365-372
- Wester, H.J.¹ Hamacher, K.² Stöcklin, G.³

18
- 0023178724
- a) M. R. Kilbourn, C. S. Dence, M. J. Welch, C. J. Mathias, J. Nucl. Med. 1987, 28, 462-470;
- (1987) J. Nucl. Med , vol.28 , pp. 462-470
- Kilbourn, M.R.¹ Dence, C.S.² Welch, M.J.³ Mathias, C.J.⁴

19
- 0344013630
- b) T. Toyokuni, J. C. Walsh, A. Dominguez, M. E. Phelps, J. R. Barrio, S. S. Gambhir, N. Satyamurthy, Bioconjugate Chem. 2003, 14, 1253-1259;
- (2003) Bioconjugate Chem , vol.14 , pp. 1253-1259
- Toyokuni, T.¹ Walsh, J.C.² Dominguez, A.³ Phelps, M.E.⁴ Barrio, J.R.⁵ Gambhir, S.S.⁶ Satyamurthy, N.⁷

20
- 0028471146
- c) G. Vaidyanathan, M. R. Zalutsky, Bioconjugate Chem. 1994, 5, 352-356;
- (1994) Bioconjugate Chem , vol.5 , pp. 352-356
- Vaidyanathan, G.¹ Zalutsky, M.R.²

21
- 0028452894
- d) S. Guhlke , H. H. Coenen, G. Stöcklin, Appl. Radiat. Isot. 1994, 45, 715-727;
- (1994) Appl. Radiat. Isot , vol.45 , pp. 715-727
- Guhlke, S.¹ Coenen, H.H.² Stöcklin, G.³

22
- 0024473886
- e) Y. Shai, K. L. Kirk, M. A. Channing, B. B. Dunn, M. A. Lesniak, R. C. Eastman, R. D. Finn, J. Roth, K. A. Jacobson, Biochemistry 1989, 28, 4801-4806;
- (1989) Biochemistry , vol.28 , pp. 4801-4806
- Shai, Y.¹ Kirk, K.L.² Channing, M.A.³ Dunn, B.B.⁴ Lesniak, M.A.⁵ Eastman, R.C.⁶ Finn, R.D.⁷ Roth, J.⁸ Jacobson, K.A.⁹

23
- 0028670748
- f) L. Lang, W. C. Eckelman, Appl. Radiat. Isot. 1994, 45, 1155-1163;
- (1994) Appl. Radiat. Isot , vol.45 , pp. 1155-1163
- Lang, L.¹ Eckelman, W.C.²

24
- 33644938767
- g) K. Bruus-Jensen, T. Poethko, M. Schottelius, A. Hauser, M. Schwaiger, H.-J. Wester, Nucl. Med. Biol. 2006, 33, 173-183.
- (2006) Nucl. Med. Biol , vol.33 , pp. 173-183
- Bruus-Jensen, K.¹ Poethko, T.² Schottelius, M.³ Hauser, A.⁴ Schwaiger, M.⁵ Wester, H.-J.⁶

25
- 0000621692
- N. S. Marans, L. H. Sommer, F. C. Whitmore, J. Am. Chem. Soc. 1951, 73, 5127-5130.
- (1951) J. Am. Chem. Soc , vol.73 , pp. 5127-5130
- Marans, N.S.¹ Sommer, L.H.² Whitmore, F.C.³

26
- 0032778310
- a) J. C. Walsh, K. M. Akhoon, N. Satyamurthy, J. R. Barrio, M. E. Phelps, S. S. Gambhir, T. Toyokuni, J. Labelled Compd. Radiopharm. 1999, 42, S1-S3;
- (1999) J. Labelled Compd. Radiopharm , vol.42
- Walsh, J.C.¹ Akhoon, K.M.² Satyamurthy, N.³ Barrio, J.R.⁴ Phelps, M.E.⁵ Gambhir, S.S.⁶ Toyokuni, T.⁷

27
- 0022059526
- b) L. G. Hutchins, A. L. Bosch, M. S. Rosenthal, R. J. Nickles, S. J. Gatley, Int. J. Appl. Radiat. Isot. 1985, 36, 375-378.
- (1985) Int. J. Appl. Radiat. Isot , vol.36 , pp. 375-378
- Hutchins, L.G.¹ Bosch, A.L.² Rosenthal, M.S.³ Nickles, R.J.⁴ Gatley, S.J.⁵

28
- 53549134407
- U. Choudhry, R. Paul, S. C. Biagini, P. J. Blower, Eur. J. Nucl. Med. Mol. Imaging 2007, 34, S332.
- (2007) Eur. J. Nucl. Med. Mol. Imaging , vol.34
- Choudhry, U.¹ Paul, R.² Biagini, S.C.³ Blower, P.J.⁴

29
- 53549102383
- a) R. Schirrmacher, G. Bradtmoeller, E. Schirrmacher, O. Thews, J. Tillmanns, T. Siessmeier, H. G. Bucholz, P. Bartenstein, B. Wängler, C. M. Niemeyer, K. Jurkschat, Angew. Chem. 2006, 118, 6193-6197;
- (2006) Angew. Chem , vol.118 , pp. 6193-6197
- Schirrmacher, R.¹ Bradtmoeller, G.² Schirrmacher, E.³ Thews, O.⁴ Tillmanns, J.⁵ Siessmeier, T.⁶ Bucholz, H.G.⁷ Bartenstein, P.⁸ Wängler, B.⁹ Niemeyer, C.M.¹⁰ Jurkschat, K.¹¹

30
- 33748785714
- Angew. Chem. Int. Ed. 2006, 45, 6047-6050;
- (2006) Angew. Chem. Int. Ed , vol.45 , pp. 6047-6050

31
- 36849050857
- b) E. Schirrmacher, B. Wängler, M. Cypryk, G. Bradtmoeller, M. Schäfer, M. Eisenhut, K. Jurkschat, R. Schirrmacher, Bioconjugate Chem. 2007, 18, 2085-2089.
- (2007) Bioconjugate Chem , vol.18 , pp. 2085-2089
- Schirrmacher, E.¹ Wängler, B.² Cypryk, M.³ Bradtmoeller, G.⁴ Schäfer, M.⁵ Eisenhut, M.⁶ Jurkschat, K.⁷ Schirrmacher, R.⁸

32
- 25444520557
- R. Ting, M. J. Adam, T. J. Ruth, D. M. Perrin, J. Am. Chem. Soc. 2005, 127, 13094-13095.
- (2005) J. Am. Chem. Soc , vol.127 , pp. 13094-13095
- Ting, R.¹ Adam, M.J.² Ruth, T.J.³ Perrin, D.M.⁴

33
- 53549133824
- For stability studies, the fluorosilane model compound (2 mg) was dissolved in acetonitrile/aqueous buffer (2:1, 1.5 mL, pH 7.0) at room temperature (23°C) and hydrolysis was monitored by reversed-phase HPLC after different intervals.
- For stability studies, the fluorosilane model compound (2 mg) was dissolved in acetonitrile/aqueous buffer (2:1, 1.5 mL, pH 7.0) at room temperature (23°C) and hydrolysis was monitored by reversed-phase HPLC after different intervals.

34
- 0003714939
- Oxford University Press, Oxford
- W. C. Chan, P. D. White, Fmoc Solid Phase Peptide Synthesis - A Practical Approach, Oxford University Press, Oxford, 2003.
- (2003) Fmoc Solid Phase Peptide Synthesis - A Practical Approach
- Chan, W.C.¹ White, P.D.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.